[1]纪东华,张 涛.股总动脉闭塞性病变治疗现状[J].介入放射学杂志,2021,30(07):739-742.
　JI Donghua,ZHANG Tao..Current status concerning the treatment of common femoral artery occlusive diseases[J].journal interventional radiology,2021,30(07):739-742.

点击复制

股总动脉闭塞性病变治疗现状()

PDF下载中关闭

• 
• 
• 

分享到：

参考文献/References:

［1］ Norgren L，Hiatt WR，Dormandy JA，et al. Inter- society consensus for the management of peripheral arterial disease（TASC Ⅱ）［J］. J Vasc Surg， 2007， 45（Suppl S）：S5-S67.
［2］ Aboyans V， Ricco JB， Bartelink MEL， et al. 2017 ESC guidelines on the diagnosis and treatment of peripheral arterial diseases，in collaboration with the European Society for Vascular Surgery（ESVS）：document covering atherosclerotic disease of extracranial carotid and vertebral，mesenteric，renal，upper and lower extremity arteries endorsed by： the European Stroke Organization（ESO） the task force for the diagnosis and treatment of peripheral arterial diseases of the European Society of Cardiology（ESC） and of the European Society for Vascular Surgery（ESVS）［J］. Eur Heart J， 2018， 39： 763-816.
［3］ Cardon A， Aillet S， Jarno P， et al. Endarteriectomy of the femoral tripod： long- term results and analysis of failure factors［J］. Ann Chir， 2001， 126： 777-782.
［4］ Kang JL， Patel VI， Conrad MF， et al. Common femoral artery occlusive disease： contemporary results following surgical endar- terectomy［J］. J Vasc Surg， 2008， 48： 872- 877.
［5］ Kechagias A， Ylonen K， Biancari F. Long-term outcome after isolated endarterectomy of the femoral bifurcation［J］. World J Surg， 2008， 32： 51-54.
［6］ Wong G， Lahsaei S， Aoun J， et al. Management of common femoral artery occlusive disease： a review of endovascular treatment strategies and outcomes［J］. Catheter Cardiovasc Interv， 2019， 93： 514-521.
［7］ Andrews RT， Venbrux AC， Magee CA， et al. Placement of a flexible endovascular stent across the femoral joint： an in vivo study in the swine model［J］. J Vasc Interv Radiol， 1999， 10： 1219-1228.
［8］ Ballard JL， Sparks SR， Taylor FC， et al. Complications of iliac artery stent deployment［J］. J Vasc Surg， 1996， 24： 545-553.
［9］ Azema L， Davaine JM， Guyomarch B， et al. Endovascular repair of common femoral artery and concomitant arterial lesions［J］. Eur J Vasc Endovasc Surg， 2011， 41： 787-793.
［10］ Nguyen BN， Amdur RL， Abugideiri M， et al. Postoperative compli-cations after common femoral endarterectomy［J］. J Vasc Surg， 2015， 61： 1489e1-1494e1.
［11］ Wieker CM， Schonefeld E， Osada N， et al. Results of common femoral artery thromboendarterectomy evaluation of a traditional surgical management in the endovascular era［J］. J Vasc Surg， 2016， 64： 995-1001.
［12］ Goueffic Y， Della SN， Thaveau F， et al. Stenting or surgery for de novo common femoral artery stenosis［J］. JACC Cardiovasc Interv， 2017， 10： 1344-1354.
［13］ Dormandy JA， Rutherford RB. Management of peripheral arterial disease（PAD）. TASC Working Group. TransAtlantic Inter-Society Consensus（TASC）［J］. J Vasc Surg， 2000， 31（1 Pt 2）： S1- S296.
［14］ Mehta M， Zhou Y， Paty PS， et al. Percutaneous common femoral artery interventions using angioplasty， atherectomy， and stenting［J］. J Vasc Surg， 2016， 64： 369-379.
［15］ Johnston KW， Rae M， Hogg-Johnston SA， et al. 5-year results of a prospective study of percutaneous transluminal angioplasty［J］. Ann Surg， 1987， 206： 403-413.
［16］ Bonvini RF， Rastan A， Sixt S， et al. Endovascular treatment of common femoral artery disease： medium- term outcomes of 360 consecutive procedures［J］. J Am Coll Cardiol， 2011， 58： 792-798.
［17］ Bonvini RF， Rastan A， Sixt SA， et al. Angioplasty and provisional stent treatment of common femoral artery lesions［J］. J Vasc Interv Radiol， 2013， 24： 175-183.
［18］ Siracuse JJ， Van Orden K， Kalish JA， et al. Endovascular treatment of the common femoral artery in the Vascular Quality Initiative［J］. J Vasc Surg， 2017， 65： 1039-1046.
［19］ Davies RS， Adair W， Bolia A， et al. Endovascular treatment of the common femoral artery for limb ischemia［J］. Vasc Endovas- cular Surg， 2013， 47： 639- 644.
［20］ Dattilo PB， Tsai TT， Kevin RR， et al. Acute and medium- term outcomes of endovascular therapy of obstructive disease of diverse etiology of the common femoral artery［J］. Catheter Cardiovasc Interv， 2013， 81： 1013-1022.
［21］ Bath J， Avgerinos E. A pooled analysis of common femoral and profunda femoris endovascular interventions［J］. Vascular， 2016， 24： 404-413.
［22］ Nasr B，Kaladji A，Vent PA，et al. Long- term results of common femoral artery stenting［J］. Ann Vasc Surg， 2017， 40：10-18.
［23］ Thiney PO， Millon A， Boudjelit T， et al. Angioplasty of the common femoral artery and its bifurcation［J］. Ann Vasc Surg， 2015， 29： 960-967.
［24］ Baumann F， Ruch M， Willenberg T， et al. Endovascular treatment of common femoral artery obstructions［J］. J Vasc Surg， 2011， 53： 1000-1006.
［25］ Deloose K， Martins I， Neves C， et al. Endovascular treatment for the common femoral artery： is there a challenger to open surgery?［J］. J Cardiovasc Surg（Torino）， 2019， 60： 8-13.
［26］ Stavroulakis K， Schwindt A， Torsello G， et al. Directional atherectomy with antirestenotic therapy vs drug- coated balloon angioplasty alone for common femoral artery atherosclerotic disease［J］. J Endovasc Ther， 2018， 25： 92- 99.
［27］ Cantu D， Jawaid O， Kokkinidis D， et al. Outcomes of drug- coated balloon angioplasty vs. conventional balloon angioplasty for endovascular treatment of common femoral artery atherosclerotic disease［J］. Cardiovasc Revasc Med， 2020， 21： 867-874.
［28］ Davaine JM， Quillard T， Chatelais M， et al. Bone like arterial calcification in femoral atherosclerotic lesions： prevalence and role of osteoprotegerin and pericytes［J］. Eur J Vasc Endovasc Surg， 2016， 51： 259-267.
［29］ Guo J， Guo LR， Tong Z， et al. Directional atherectomy is associated with better long- term efficiency compared with angioplasty for common femoral artery occlusive disease in rutherford 2- 4 patients［J］. Ann Vasc Surg， 2018， 51： 65-71.
［30］ Cioppa A， Stabile E， Salemme L， et al. Combined use of directional atherectomy and drug- coated balloon for the endovascular treatment of common femoral artery disease： immediate and one-year outcomes［J］. EuroIntervention， 2017， 12： 1789-1794.
［31］ Picazo F， Kwok RCH， Hockley JA， et al. Directional atherectomy of the common femoral artery： complications and outcomes［J］. Ann Vasc Surg， 2020， 66： 621-630.
［32］ Linni K， Ugurluoglu A， Hitzl W， et al. Bioabsorbable stent implan-tation vs. common femoral artery endarterectomy： early results of a randomized trial［J］. J Endovasc Ther， 2014， 21： 493-502.
［33］ Brodmann M， Schwindt A， Argyriou A， et al. Safety and feasibility of intravascular lithotripsy for treatment of common femoral artery stenoses［J］. J Endovasc Ther， 2019， 26： 283-287.